Loading
Anhedonia / Mental Health Disorder / Suicide · Interventional Study
ClinicalTrials.gov · August 12, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a completed micro-randomized trial designed to optimize engagement with ViraBrite, a digital suicide safety planning app augmented with just-in-time adaptive intervention features. The registry record contains no results; primary outcomes are proximal engagement at 24 hours and 4 weeks, not clinical safety or effectiveness. Readers should await full results before drawing conclusions about efficacy or clinical utility.
Interventional, Single Group, Open label, Prevention purpose. Suicide, Mental Health Disorder, Anhedonia; age from 13 Years; to 18 Years. Intervention: ViraBrite. n = 24. 1 site: United States.
This is a completed micro-randomized trial designed to optimize engagement with ViraBrite, a digital suicide safety planning app augmented with just-in-time adaptive intervention features. The registry record contains no results; primary outcomes are proximal engagement at 24 hours and 4 weeks, not clinical safety or effectiveness. Readers should await full results before drawing conclusions about efficacy or clinical utility.
Primary outcomes are engagement metrics, not clinical or safety outcomes.
The source did not state who this applies to in practice.
This is a completed feasibility/optimization trial with no results posted; it uses a micro-randomized design to test engagement with a digital intervention component, not a clinical outcome.
As stated by the source record.
Quoted from the source exactly as published.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT06665620). This is a study registration, not published results. Lead sponsor: Ksana Health. Recruitment status: COMPLETED. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 24 participants (ACTUAL). Conditions: Suicide, Mental Health Disorder, Anhedonia. Interventions: BEHAVIORAL: ViraBrite nudges. Primary outcome measures: Proximal engagement with ViraBrite , 24 hours; Engagement with ViraBrite , 4 weeks. Brief summary: Despite efforts to prevent suicide, US rates are climbing, and suicide is the second leading cause of death amongst youth. Digital tools, especially personal smartphones, are promising avenues to address these issues and can be used to increase engagement with effective interventions such as suicide safety planning. The BRITE suicide safety planning app was developed on evidence-based principles and has undergone rigorous formative development and effectiveness evaluations. However, to optimize its functionality, commercial viability, and scale its implementation, issues related to user engagement need to be addressed. This 4-week Micro-Randomized Trial (MRT) will optimize specific components of ViraBrite, an augmented version of the BRITE suicide safety planning app that integrates automated algorithms (i.e., just in time adaptive intervention features) to facilitate increased engagement with coping skills and pushes safety planning materials to users at periods of high risk (i.e., increases in emotional distress).
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.